subject area of
- A Multicenter Open-Label Study to Assess the Safety of a New Formulation of BLP25 Liposome Vaccine in Patients With Unresectable Stage III Non–Small-Cell Lung Cancer Academic Article
- A Recombinant Modified Vaccinia Ankara Vaccine Encoding Epstein–Barr Virus (EBV) Target Antigens: A Phase I Trial in UK Patients with EBV-Positive Cancer Academic Article
- A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer Academic Article
- A rational relationship: Oncolytic virus vaccines as functional partners for adoptive T cell therapy Academic Article
- Adenoviral-transduced dendritic cells are susceptible to suppression by T regulatory cells and promote interleukin 17 production Academic Article
- Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination Academic Article
- Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas Academic Article
- Bone Marrow-Derived Dendritic Cell Vaccination of Dogs with Naturally Occurring Melanoma by Using Human gp100 Antigen Academic Article
- CD4+ T-cell-mediated anti-tumor immunity can be uncoupled from autoimmunity via the STAT4/STAT6 signaling axis Academic Article
- CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cells Academic Article
- CTL-Dependent and -Independent Antitumor Immunity Is Determined by the Tumor Not the Vaccine Academic Article
- Cancer immunology and canine malignant melanoma: A comparative review Academic Article
- Cell-based cancer gene therapy: breaking tolerance or inducing autoimmunity? Academic Article
- Cell-free Tumor Microparticle Vaccines Stimulate Dendritic Cells via cGAS/STING Signaling Academic Article
- Cellular MRI as a suitable, sensitive non-invasive modality for correlating in vivo migratory efficiencies of different dendritic cell populations with subsequent immunological outcomes Academic Article
- Cellular magnetic resonance imaging of monocyte-derived dendritic cell migration from healthy donors and cancer patients as assessed in a scid mouse model Academic Article
- Combined Stimulation with Interleukin-18 and Interleukin-12 Potently Induces Interleukin-8 Production by Natural Killer Cells Academic Article
- Combining oncolytic virotherapy and tumour vaccination Academic Article
- Customized Viral Immunotherapy for HPV-Associated Cancer Academic Article
- Dendritic Cells Transduced with an Adenoviral Vector Encoding a Model Tumor-Associated Antigen for Tumor Vaccination Academic Article
- Detection of Tumor Antigen-Specific T-Cell Responses After Oncolytic Vaccination Academic Article
- Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines Academic Article
- Endogenous T cells prevent tumor immune escape following adoptive T cell therapy Academic Article
- Engineering Dendritic Cells to Enhance Cancer Immunotherapy Academic Article
- Enhanced Antitumor Immunity Elicited by Dendritic Cell Vaccines Is a Result of Their Ability to Engage Both CTL and IFNγ-producing NK Cells Academic Article
- Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor Academic Article
- Enhanced Immune Response to the Melanoma Antigen gp100 Using Recombinant Adenovirus-Transduced Dendritic Cells Academic Article
- Enhanced antitumor immunity elicited by dendritic cell vaccines is a result of their ability to engage both CTL and IFN gamma-producing NK cells. Academic Article
- Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning Academic Article
- Enhanced protein expression by internal ribosomal entry site-driven mRNA translation as a novel approach for in vitro loading of dendritic cells with antigens Academic Article
- Enhancing Immune Responses to Cancer Vaccines Using Multi-Site Injections Academic Article
- Genetically modified dendritic cells in cancer therapy: Implications for transfusion medicine Academic Article
- Genetically modified dendritic cells prime autoreactive T cells through a pathway independent of CD40L and interleukin 12: implications for cancer vaccines. Academic Article
- Going viral with cancer immunotherapy Academic Article
- Harnessing Oncolytic Virus-mediated Antitumor Immunity in an Infected Cell Vaccine Academic Article
- High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome Academic Article
- IL-15 and Type I Interferon Are Required for Activation of Tumoricidal NK Cells by Virus-Infected Dendritic Cells Academic Article
- Immuno-gene therapy approaches for cancer: from in vitro studies to clinical trials Academic Article
- Immunotherapy Can Reject Intracranial Tumor Cells without Damaging the Brain despite Sharing the Target Antigen Academic Article
- Immunotherapy-induced CD8+ T Cells Instigate Immune Suppression in the Tumor Academic Article
- Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12 Academic Article
- Induction of specific human cytotoxic T cells using dendritic cells transduced with an adenovector encoding rat epidermal growth factor receptor 2 Academic Article
- Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study Academic Article
- Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial Academic Article
- Maraba Virus as a Potent Oncolytic Vaccine Vector Academic Article
- Maraba virus-vectored cancer vaccines represent a safe and novel therapeutic option for cats Academic Article
- Mesenchymal Stromal Cells Expressing ErbB-2/neu Elicit Protective Antibreast Tumor Immunity In vivo, Which Is Paradoxically Suppressed by IFN-γ and Tumor Necrosis Factor-α Priming Academic Article
- Multi-Stability and Multi-Instability Phenomena in a Mathematical Model of Tumor-Immune-Virus Interactions Academic Article
- Neoadjuvant Vaccination Provides Superior Protection against Tumor Relapse following Surgery Compared with Adjuvant Vaccination Academic Article
- Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer Academic Article
- Oncolytic Viruses: Therapeutics With an Identity Crisis Academic Article
- Postoperative Adjuvant Dendritic Cell–Based Immunotherapy in Patients with Relapsed Glioblastoma Multiforme Academic Article
- Preclinical development of peptide vaccination combined with oncolytic MG1-E6E7 for HPV-associated cancer Academic Article
- Preface Academic Article
- Prolonged Culture of Vaccine-Primed Lymphocytes Results in Decreased Antitumor Killing and Change in Cytokine Secretion Academic Article
- Randomized Phase IIB Trial of BLP25 Liposome Vaccine in Stage IIIB and IV Non–Small-Cell Lung Cancer Conference Paper
- Sarcomas and the Immune System: Implications for Therapeutic Strategies Academic Article
- Stratification according to HGG-IMMUNO RPA model predicts outcome in a large group of patients with relapsed malignant glioma treated by adjuvant postoperative dendritic cell vaccination Academic Article
- Surgical Stress Abrogates Pre-Existing Protective T Cell Mediated Anti-Tumor Immunity Leading to Postoperative Cancer Recurrence Academic Article
- T-cell immunity generated by recombinant adenovirus vaccines Academic Article
- Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial Academic Article
- Therapeutic options in advanced prostate cancer: Present and future Academic Article
- Tn-MUC1 DC Vaccination of Rhesus Macaques and a Phase I/II Trial in Patients with Nonmetastatic Castrate-Resistant Prostate Cancer Academic Article
- Tumor Protection Following Vaccination With Low Doses of Lentivirally Transduced DCs Expressing the Self-antigen erbB2 Academic Article
- Type I IFN signaling on dendritic cells is required for NK cell-mediated anti-tumor immunity Academic Article
- Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial Academic Article
- Vaccination-Induced Autoimmune Vitiligo Is a Consequence of Secondary Trauma to the Skin Academic Article
- Vesicular Stomatitis Virus as a Novel Cancer Vaccine Vector to Prime Antitumor Immunity Amenable to Rapid Boosting With Adenovirus Academic Article
- Vesicular stomatitis virus: re-inventing the bullet Academic Article
- [Ad hTRP2 - mediated immunity against melanoma is enhanced by dendritic cells pulsed with peptide]. Academic Article